FAUCI DIARY ARCHIVE — Thursday, November 30, 2023
https://faucisdiary.com/diary/2023-11-30

Text below is verbatim from the released PDFs, with the original line breaks.
==============================================================================

EMAIL — RE: For your awareness: materials requested for Dr. Tabak
From: Jeanne Marrazzo
To: Sara Selgrade
Cc: Hugh Auchincloss, Jill Harper, Courtney Billet, NIAID OCGR Leg
Sent: Thu, 30 Nov 2023 07:42:04 -0500
Source: Reading Room, p. 185 of Reading-Room-FINAL.pdf
------------------------------------------------------------------------------
Thanks Sara, this is a very comprehensive and helpful document. JM

****************************************************
Jeanne Marrazzo, MD, MPH
Director, National Institute of Allergy and Infectious Diseases
Building 31, Room 7A-03
31 Center Drive, MSC 2520
National Institutes of Health
Bethesda, MD 20892-2520

NIAID Front Office Phone
Fax:

From: Selgrade, Sara (NIH/NIAID) [E]                @nih.gov>
Sent: Wednesday, November 29, 2023 7:30 PM
To: Marrazzo, Jeanne (NIH/NIAID) [E]                  @nih.gov>
Cc: Auchincloss, Hugh (NIH/NIAID) [E]              @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E]       @niaid.nih.gov>;
Billet, Courtney (NIH/NIAID) [E]       @niaid.nih.gov>; NIAID OCGR Leg                   @mail.nih.gov>
Subject: For your awareness: materials requested for Dr. Tabak

Hello Dr. Marrazzo,

NIH OLPA has asked for NIAID assistance with preparing background materials for Dr. Tabak for a potential congressional
staff briefing.

As you are aware, there has been recent congressional interest in certain coronavirus studies conducted at RML. It is
possible that Dr. Tabak may provide a briefing on this research to staff to the House Labor-HHS Appropriations
Subcommittee (Chair: Rep. Robert Aderholt, R-AL) in the coming weeks. NIH OLPA has asked us to review a draft
background document for Dr. Tabak. The NIH Office of Research Services (Division of Occupational Health and Safety) has
reviewed as well.

The legislative team worked with DIR/RML to add information requested by OLPA and make additional NIAID edits for
accuracy. The attached document with NIAID edits was reviewed by Hugh, Jill, and Courtney, and will be provided to NIH
OLPA for review and potential use by Dr. Tabak.

Please let me know if you have any questions.

Thanks,
Sara